small cell lung cancer

Small cell lung cancer (SCLC) accounts for about 20% of lung cancers. It has a high degree of malignancy, short doubling time, early and extensive metastasis, sensitive to chemotherapy and radiotherapy, and high initial treatment remission rate, but it is very prone to secondary Drug resistance, easy to relapse, treatment is based on systemic chemotherapy.